^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

multi-CAR-T cell therapy

i
Other names: multi-CAR-T cell therapy, 4SCAR19 and 4SCAR20/22/70/PSMA/13/79b/GD2
Associations
Company:
SZGIMI
Drug class:
CD19-targeted CAR-T immunotherapy, CD20-targeted CAR-T immunotherapy, CD70-targeted CAR-T immunotherapy, CD22-targeted CAR-T immunotherapy, PSMA-targeted CAR-T immunotherapy, CD13-targeted CAR-T immunotherapy, CD79b-targeted CAR-T immunotherapy, GD2-targeted CAR-T immunotherapy
Related drugs:
Associations